Kuehn Law Encourages FIXX, SCTL, EVRI, and GRPH Investors to Contact Law Firm
NEW YORK, March 01, 2024 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures or other relief on behalf of the shareholders of these companies.
Kuehn Law is investigating whether the Boards of the below companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process:
- Homology Medicines, Inc. (Nasdaq: FIXX) click to participate
Homology Medicines has agreed to merge with Q32 Bio. Under the agreement’s terms, Homology shareholders will own approximately 25% of the combined company.
- Societal CDMO, Inc. (Nasdaq: SCTL) click to participate
Societal CDMO has agreed to be acquired by CoreRx. Under the agreement, shareholders of Societal CDMO will be entitled to a payment of $1.10 per share in cash.
- Everi Holdings Inc. (NYSE: EVRI) click to participate
Everi Holdings has agreed to merge with International Game Technology. Under the proposed transaction, Everi shareholders are expected to own approximately 46% of the combined company.
- Graphite Bio, Inc. (Nasdaq: GRPH) click to participate
Graphite Bio has agreed to combine with LENZ Therapeutics. Under the proposed transaction, Graphite Bio shareholders are expected to own approximately 35% of the combined company.
Why Your Participation Matters:
As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future.™
How to Get Involved:
Kuehn Law is dedicated to safeguarding shareholder interests. Concerned shareholders are encouraged to contact Justin Kuehn, Esq., at justin@kuehn.law or call (833) 672-0814. Kuehn Law covers all case costs and does not charge its investor clients. Shareholders are advised to act promptly, as legal rights may be time-sensitive. For additional information, please visit Merger Litigation - Kuehn Law.
Attorney advertising. Prior results do not guarantee similar outcomes.
Contacts:
Kuehn Law, PLLC
Justin Kuehn, Esq.
53 Hill Street, Suite 605
Southampton, NY 11968
justin@kuehn.law
(833) 672-0814
-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Berkshire Hathaway Earnings: Strong Insurance Results Continue to Lift Revenue and Profitability
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom